Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study by Elena Barbuti, Alessia Castiello, Valeria Pozzilli, Antonio Carotenuto, Ilaria Tomasso, Marcello Moccia, Serena Ruggieri, Giovanna Borriello, Roberta Lanzillo, Vincenzo Brescia Morra, Carlo Pozzilli, Maria Petracca

Get full text

The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study. by Emanuele D'Amico, Carmela Leone, Giusi Graziano, Maria Pia Amato, Roberto Bergamaschi, Paola Cavalla, Gabriella Coniglio, Giancarlo Di Battista, Maria Teresa Ferrò, Franco Granella, Enrico Granieri, Alessandra Lugaresi, Giacomo Lus, Enrico Millefiorini, Carlo Pozzilli, Gioacchino Tedeschi, Mario Zappia, Giancarlo Comi, Maria Trojano, Vito Lepore, Francesco Patti

Get full text

The role of microglia in multiple sclerosis: implications for treatment with Bruton’s tyrosine kinase inhibitors by Patrick Vermersch, Laura Airas, Laura Airas, Thomas Berger, Thomas Berger, Florian Deisenhammer, Nikolaos Grigoriadis, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Melinda Magyari, Melinda Magyari, Veronica Popescu, Veronica Popescu, Veronica Popescu, Carlo Pozzilli, Maura Pugliatti, Maura Pugliatti, Bart Van Wijmeersch, Bart Van Wijmeersch, Bart Van Wijmeersch, Magd Zakaria, Celia Oreja-Guevara, Celia Oreja-Guevara

Get full text